Background: Patients with chronic heart failure (CHF) present microcirculation alterations and vascular endothelial dysfunction. Exercise training programs have been shown to improve the functional status of these patients, however less is known yet about the acute systemic effect of exercise on peripheral muscle microcirculation. The aim of the present study was to investigate the acute effect of a respiratory muscle exercise bout on the microcirculation of non-exercising muscles (systemic effect). Materials and Methods: Thirty-four (30♂/4♀) stable CHF patients, with a mean age of61.4±9.2 years, ejection fraction (EF): 33.9±7.8%, maximal inspiratory pressure (MIP): 78.2±27.1 cmH2O, VO2max: 17.5±4.05 ml/kg/min, VE/VCO2 slope: 32.7±6.4 and a New York Heart Association classification (NYHA) ≥ ΙΙ participated in the study. Microcirculatory assessment was performed at rest and immediately after the respiratory exercise program (5 sets/10 repetitions, training load: 60% of MIP). Basal tissue oxygen saturation (StO2),oxygen consumption rate (OCR) and reperfusion rate (RR) were measured utilizing near-infrared spectroscopy(NIRS) at the thenar muscle along with the vascular occlusion test (VOT). Results: RR (%/min), following the release of vascular occlusion, as well as OCR (%/min) increased after the respiratory exercise program (from 3.4±1.6 to 3.9±1.7, p=0.007, and from 12.7±3.8 to 13.2±3.9, p=0.021 respectively), whereas the corresponding basal StO2values difference did not reach the level of statistical significance (from 85.5±6.4. to 84.7±6.2, p=0.065). Conclusions: In the present study, concerning patients with CHF, after an acute respiratory exercise bout, dynamic microcirculatory indices assessed by NIRS in peripheral, non-exercising muscles, were significantly altered.
Background: Patients with heart failure (HF) have impaired function of respiratory system and frequently experience dyspnea. Inspiratory muscle training (IMT) offers an alternative way of exercise with a lot of benefits for HF patients. Aim: The aim of this review was to summarize and to reveal the effects of IMT in HF patients. Methods: Electronic searches were performed using Pubmed Database, Physiotherapy Evidence Database (PEDro) and Cochrane Library. Inclusion criteria were: RCTs, patients with HF, full text articles after 2010 and at least one intervention group with IMT. Methodological quality was assessed using the PEDro (Physiotherapy Evidence Database) scale. Results: Nineteen articles met the inclusion criteria and were included in this review. In most studies training protocols involved 3 to 7 sessions per week with intensity ≤30-60% of maximal inspiratory pressure (MIP), for a total duration of 4-12 weeks. Respiratory muscle strength improved in 11/12 studies, peripheral muscle strength in 4/5 studies, exercise capacity (peak VO2, VE/VCO2 slope) in 4/10, pulmonary function (FEV1, FEV1/FVC, FVC) in 0/5, functional capacity (6MWT) in 6/8, echocardiography parameters in 1/6, quality of life and dyspnea in 9/16. Control groups followed sham IMT, usual care, no intervention, intervention without exercise, or aerobic training, which could explain in some cases the conflicting results. Conclusions: IMT is beneficial for HF patients and should be included as a complementary method in cardiac rehabilitation programs. The optimal characteristics of ΙΜΤ as well as the benefits when combined with common forms of exercise need further research.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.